Aikido Pharma

Die ehemalige Spherix Inc. heisst nach Durchführung eines Namenswechsels seit 13.03.2020 nunmehr Aikido Pharma Inc. Der äußerst volatile Biotechnologietitel wird unter dem Ticker "AIKI" an der NASDAQ sowie unter der WKN A2P1UN an diversen deutschen Börsen notiert.

https://www.prnewswire.com/news-releases/...pharma-inc-301023121.html

 

https://finance.yahoo.com/news/...rporated-coronavirus-165200089.html  

Gem. beigefügtem Artikel heißt die Firma jetzt "Alkido Pharma" und nicht wie derzeit bei Ariva hinterlegt "Aikido Pharma". Wahrscheinlich war das neue Tickersymbol "AIKI" ausschlaggebend für den teilweise auch bei anderen Datenprovidern bestehenden Fehler.

Jetzt müssen wir mal abwarten, was die Firma in den nächsten Tagen hinsichtlich ihrer Aktivitäten zur Bekämpfung des Coronavirus berichtet...

https://microcapdaily.com/...nt-lifts-spherix-inc-nasdaq-spex/125497/  

Am Freitag, 20.03.2020, hat Alkido in einem Press Release auch noch ein neues Mitglied im Advisory Board bekanntgegeben:

https://www.nasdaq.com/press-release/...-to-advisory-board-2020-03-20  

"Methods of treating coronavirus infection"

2020-03-22 Application status is Active

The present invention provides methods for treating a coronavirus infection. For example, treatment may be effected by administering a neurotransmitter inhibitor, a signaling kinase inhibitor, an estrogen receptor inhibitor, a DNA metabolism inhibitor or an anti-parasitic agent. Also provided are methods for treating a coronavirus infection in which an anti-viral drug also is administered during any of the described methods.

https://patents.google.com/patent/US10434116B2/en

 

https://alphastocknews.com/...ds-up-on-coronavirus-anticipation/2898/  

https://alphastocknews.com/...ds-up-on-coronavirus-anticipation/2898/  

https://www.prnewswire.com/news-releases/...tax-assets-301028621.html  

on COVID-19, Dividend, And Path Forward

https://ih.advfn.com/stock-market/NASDAQ/...r-update-on-covid-19-divi  

RTQ USD 2,21 +237%

https://ir.aikidopharma.com/news-releases/  

.. gewartet, schönen Gewinn schon eingestrichen und Rest mal weiter laufen lassen, glaube das Ende der Fahnenstange ist heute noch nicht erreicht..  

 

 

NEW YORK, April 14, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company"), today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 14,000,000 shares of AIkido's common stock, at a purchase price of $1.00 per share, in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about April 16, 2020, subject to the satisfaction of customary closing conditions.  

 

https://old.nasdaq.com/symbol/aiki/real-time  

und zwar bei 2,16 € verkauft...

 

NEW YORK, April 15, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company"), a technology development company committed to the fostering of innovative ideas, announced today the closing of its previously announced registered direct offering with several institutional and accredited investors of 14,000,000 shares of its common stock at a purchase price of $1.00 per share, priced at-the-market under Nasdaq rules. The gross proceeds to the Company from the offering totaled $14.0 million, before deducting placement agent fees and other offering expenses.  

 

NEW YORK, April 20, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the record date for the previously announced distribution to our stockholders of shares of Hoth Therapeutics, Inc. ("Hoth") is April 30, 2020, and the Company is currently working to determine the date of distribution.  

Auch mich würde es interessieren was hier bei Aikido abgeht!  

NEW YORK, April 21, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that on April 13, 2020, the Company executed a Master License Agreement (the "License Agreement") with the University of Maryland, Baltimore ("UMB"). The License Agreement covers specific antiviral compounds discovered by UMB. The compounds seek to inhibit replication of multiple viruses, including Influenza virus, SARS-CoV, MERS-CoV, Ebolavirus and Marburg virus.  

 

https://www.prnewswire.com/news-releases/...iotech-ltd-301054142.html  

schrieb jemand bei yahoo, zB. einer von den 3 Besitzern kills mit seiner Atemluft den Coronavirus!